Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Bionano Genomics, Inc. (BNGO) had Profit Margin of -92.59% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$28.51M |
|
$-26.39M |
|
$15.32M |
|
$13.19M |
|
$61.85M |
|
$-33.34M |
|
$7.01M |
|
$-26.33M |
|
$-26.33M |
|
$-26.39M |
|
$-26.39M |
|
$-26.39M |
|
$-26.39M |
|
$-33.34M |
|
$-24.58M |
|
5.45M |
|
5.45M |
|
$-4.85 |
|
$-4.85 |
|
| Balance Sheet Financials | |
$45.39M |
|
$14.85M |
|
$28.20M |
|
$73.58M |
|
$22.94M |
|
$3.48M |
|
$6.22M |
|
$29.16M |
|
$44.42M |
|
$40.08M |
|
$44.42M |
|
10.74M |
|
| Cash Flow Statement Financials | |
$-16.34M |
|
$-12.75M |
|
$24.04M |
|
$9.57M |
|
$4.51M |
|
$-5.06M |
|
$4.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
0.07 |
|
0.31 |
|
46.25% |
|
-116.95% |
|
-116.95% |
|
-86.24% |
|
-92.35% |
|
|
Profit Margin |
-92.59% |
$-16.34M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
2.81 |
|
5.48 |
|
66.58 |
|
-59.42% |
|
-65.86% |
|
-35.87% |
|
-55.10% |
|
$4.14 |
|
$-3.00 |
|
$-3.00 |
|